Experience
Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion
December 26, 2023
Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.
Related contacts
Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Izzy Lubarsky
Partner, New York
Brittany K. Wightman
Associate, San Diego
Rajdeep Roger Bains
Associate, San Diego
Melissa Meza
Associate, San Diego
Will Cai
Partner, Hong Kong
Patrick Loofbourrow
Partner, Singapore
Jie Zhang
Partner, Hong Kong
Hilda Li
Associate, Hong Kong
Samantha Zhang
Associate, Singapore
Alessandra Murata
Partner, Palo Alto
Charity Williams
Partner, San Diego
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Natasha Leskovsek
Of Counsel, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Andrew Epstein
Special Counsel, Seattle
Dillon Martinson
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Amanda Griggs
Associate, New York
Sara Kim
Associate, Los Angeles Downtown
Patrick Sharma
Associate, Los Angeles Santa Monica
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles Downtown
Daniel Lac
Associate, San Diego
Sarah Oliai
Associate, Washington, DC
Related Practices & Industries
Carmot Therapeutics Enters Definitive Merger Agreement With Roche
December 3, 2023
Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.
Related contacts
Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Charity Williams
Partner, San Diego
David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Lauren Creel
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Kathleen O'Neill
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Tracy Rubin
Partner, Palo Alto
Phil Mitchell
Partner, New York
Charlie Kim
Partner, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Christine Graham
Special Counsel, London
Stella Sarma
Special Counsel, Brussels
J. Brian Stalter
Special Counsel, New York
Jennifer Shanley
Special Counsel, New York
Grant Schweikert
Special Counsel, Washington, DC
Kristopher Kleiner
Special Counsel, Colorado
Dani Nazemian
Special Counsel, San Diego
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Sangitha Palaniappa
Associate, Palo Alto
Tyler McClure
Associate, San Francisco
Rubin Waranch
Associate, Colorado
Melissa Meza
Associate, San Diego
Jameson Davis
Associate, Boston
Alexander Ellebracht
Associate, Palo Alto
Mor Agam
Associate, New York
Athina Gaki
Associate, Brussels
Andy Zachrich
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Umer Chaudhry
Associate, Washington, DC
Jane Jun
Associate, Palo Alto
Samara Zaifman
Associate, Palo Alto
Carly E. Gibbons
Associate, Chicago
Claire Norman
Associate, Palo Alto
Anitha Anne
Associate, San Francisco
Kristina Krasnikova
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Hitesh Patel
eDiscovery Attorney, Washington, DC
Related Practices & Industries
Bridge to Life Sells Certain Assets to TransMedics
August 3, 2023
Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics.
Related contacts
Rowook Park
Partner, San Diego
Jenny Ge
Associate, Los Angeles Santa Monica
Alison Freeman-Gleason
Of Counsel, Seattle
Melissa Meza
Associate, San Diego
Lauren Creel
Partner, Palo Alto
Patrick Pang
Associate, New York
Rishab Kumar
Partner, Palo Alto
Jonathan Rivinus
Partner, Colorado
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Ross Eberly
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Justin Kisner
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Joseph J. Kim
Associate, Palo Alto
Jameson Davis
Associate, Boston
Daniel Lac
Associate, San Diego
Cara Buchicchio
Associate, New York
Ajay Athavale
Associate, San Francisco
Xenia Chiu
Associate, Singapore
Mor Agam
Associate, New York
Rubin Waranch
Associate, Colorado
Patricia Myers
Paralegal Specialist, Colorado
Related Practices & Industries
Travere Sells Bile Acid Product Portfolio to Mirum
July 18, 2023
Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.
Related contacts
Rama Padmanabhan
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Charity Williams
Partner, San Diego
John Forrest
Associate, Boston
Melissa Meza
Associate, San Diego
David Burns
Special Counsel, Washington, DC
Amanda Griggs
Associate, New York
Jeffrey J. Tolin
Partner, New York
Ross Eberly
Partner, Los Angeles Santa Monica
Natasha Leskovsek
Of Counsel, Washington, DC
Peter Adams
Partner, San Diego
Rachel Thorn
Partner, New York
Alessandra Murata
Partner, Palo Alto
Cara Buchicchio
Associate, New York
Tony P. Guan
Associate, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Allison Kutner
Associate, New York
Patrick Van Eecke
Partner, Brussels
Wyatt Kernell
Associate, New York
Asa Henin
Special Counsel, San Diego
Related Practices & Industries
Morphimmune Announces Merger With Immunome and $125 Million Private Investment
July 5, 2023
Cooley advised Morphimmune, a private biotechnology company, in its definitive merger agreement with Immunome and $125 million private investment.
Related contacts
Tom Coll
Partner, San Diego
Barbara Borden
Partner, San Diego
Carlos Ramirez
Partner, San Diego
Dylan Kornbluth
Associate, San Diego
Polina A. Demina
Associate, New York
Melissa Meza
Associate, San Diego
Kyrsten Lundh
Associate, San Diego
Daniel Gillon
Associate, San Diego
Nyron J. Persaud
Partner, New York
Todd Gluth
Partner, San Diego
Ross Eberly
Partner, Los Angeles Santa Monica
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Joe Mandry
Associate, San Diego
Nathaniel Hearn Jr.
Associate, Chicago
Terren O'Connor
Associate, San Diego
Daniel Lac
Associate, San Diego
Eileen Leman
Associate, Los Angeles Downtown
Related Practices & Industries
Admissions & credentials
California